LENSAR is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Co.'s existing LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility. Co. is also designing, developing, and seeking regulatory clearance of a system, its ALLY Adaptive Cataract Treatment System, which combines an improved femtosecond laser with a phacoemulsification system in a single, integrated cataract treatment system. We show 14 historical shares outstanding datapoints in our LNSR shares outstanding history coverage, used to compute LNSR market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing LNSR market cap history over the course of time is important for investors
interested in comparing LNSR's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of LNSR versus a peer is one thing; comparing
LNSR market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like LNSR can fluctuate over the course of history.
With this page we aim to empower investors researching LNSR by allowing them to research the LNSR market cap history. |
Free LNSR Email Alerts:
Video: The Importance of Market Cap
